Endo Strikes $50M Opioid Deal In NY Amid Trial Tumult
By Jeff Overley ( September 9, 2021, 8:14 PM EDT) -- Endo Pharmaceuticals late Thursday announced a $50 million settlement to exit a New York opioid trial that has been thrown into disarray amid allegations the drugmaker and its Arnold & Porter lawyers concealed "damning evidence" of improper marketing involving narcotic painkillers....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.